Cargando…

Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation

BACKGROUND: This paper documents a retrospective pilot study of a novel approach for treating attention deficit hyperactivity disorder (ADHD) with amino acid precursors of serotonin and dopamine in conjunction with urinary monoamine assays subjected to organic cation transporter (OCT) functional sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hinz, Marty, Stein, Alvin, Neff, Robert, Weinberg, Robert, Uncini, Thomas
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035600/ https://www.ncbi.nlm.nih.gov/pubmed/21326653 http://dx.doi.org/10.2147/NDT.S16270

Ejemplares similares

Treatment of Attention Deficit Hyperactivity Disorder with Monoamine Amino Acid Precursors and Organic Cation Transporter Assay Interpretation [Retraction]
Publicado: (2020)

Treatment of Attention Deficit Hyperactivity Disorder with Monoamine Amino Acid Precursors and Organic Cation Transporter Assay Interpretation [Expression of Concern]
Publicado: (2020)

The discrediting of the monoamine hypothesis
por: Hinz, Marty, et al.
Publicado: (2012)

Monoamine depletion by reuptake inhibitors
por: Hinz, Marty, et al.
Publicado: (2011)

Relative nutritional deficiencies associated with centrally acting monoamines
por: Hinz, Marty, et al.
Publicado: (2012)

The dual-gate lumen model of renal monoamine transport
por: Hinz, Marty, et al.
Publicado: (2010)

Validity of urinary monoamine assay sales under the “spot baseline urinary neurotransmitter testing marketing model”
por: Hinz, Marty, et al.
Publicado: (2011)

Amino acid-responsive Crohn’s disease: a case study
por: Stein, Alvin, et al.
Publicado: (2010)

Amino acid management of Parkinson’s disease: a case study
por: Hinz, Marty, et al.
Publicado: (2011)

APRESS: apical regulatory super system, serotonin, and dopamine interaction
por: Hinz, Marty, et al.
Publicado: (2011)

5-HTP efficacy and contraindications
por: Hinz, Marty, et al.
Publicado: (2012)

A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
por: Hinz, Marty, et al.
Publicado: (2010)

Urinary neurotransmitter testing: considerations of spot baseline norepinephrine and epinephrine
por: Hinz, Marty, et al.
Publicado: (2011)

Neurotransmitter testing of the urine: a comprehensive analysis
por: Hinz, Marty, et al.
Publicado: (2010)

Association study between the monoamine oxidase A gene and attention deficit hyperactivity disorder in Taiwanese samples
por: Xu, Xiaohui, et al.
Publicado: (2007)

Childhood atopic dermatitis as a precursor for developing attention deficit/hyperactivity disorder
por: Xu, Yang-chun, et al.
Publicado: (2020)

Monoamine oxidase B gene variants associated with attention deficit hyperactivity disorder in the Indo-Caucasoid population from West Bengal
por: Karmakar, Arijit, et al.
Publicado: (2016)

Alterations in serum amino acid profiles in children with attention deficit/hyperactivity disorder
por: Skalny, Anatoly V., et al.
Publicado: (2021)

Neurodevelopmental outcomes of moderately preterm birth: precursors of attention deficit hyperactivity disorder at preschool age
por: Perricone, Giovanna, et al.
Publicado: (2013)

Association of Monoamine Oxidase A (MAOA) Gene uVNTR and rs6323 Polymorphisms with Attention Deficit and Hyperactivity Disorder in Korean Children
por: Hwang, In Wook, et al.
Publicado: (2018)

Management of attention-deficit hyperactivity disorder
por: Verma, Rohit, et al.
Publicado: (2011)

The history of attention deficit hyperactivity disorder
por: Lange, Klaus W., et al.
Publicado: (2010)

Stigma in attention deficit hyperactivity disorder
por: Mueller, Anna K., et al.
Publicado: (2012)

Attention Deficit Hyperactivity Disorder and Athletes
por: White, Russell D., et al.
Publicado: (2014)

Driving and attention deficit hyperactivity disorder
por: Fuermaier, Anselm B. M., et al.
Publicado: (2015)

Genetics of attention deficit hyperactivity disorder
por: Faraone, Stephen V., et al.
Publicado: (2018)

Neuroimaging in attention-deficit/hyperactivity disorder
por: Pereira-Sanchez, Victor, et al.
Publicado: (2021)

Attention-deficit/hyperactive disorder updates
por: Kessi, Miriam, et al.
Publicado: (2022)

Neural Markers of Methylphenidate Response in Children With Attention Deficit Hyperactivity Disorder
por: Arnett, Anne B., et al.
Publicado: (2022)

Attention-Deficit/Hyperactivity Disorder and Mortality Risk in Taiwan
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2019)

Attention deficit hyperactivity disorder (ADHD) & COVID-19: Attention deficit hyperactivity disorder: Consequences of the 1st wave
por: Insa, I., et al.
Publicado: (2021)

Training of attention functions in children with attention deficit hyperactivity disorder
por: Tucha, Oliver, et al.
Publicado: (2011)

Connectivity supporting attention in children with attention deficit hyperactivity disorder
por: Barber, Anita D., et al.
Publicado: (2014)

Attention Patterns in Children with Attention Deficit Disorder with or without Hyperactivity
por: Zalsman, Gil, et al.
Publicado: (2003)

Neurophysiological Correlates of Attentional Fluctuation in Attention-Deficit/Hyperactivity Disorder
por: Cheung, Celeste H. M., et al.
Publicado: (2017)

Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2020)

Treatment of adults with attention-deficit/hyperactivity disorder
por: Kolar, Dusan, et al.
Publicado: (2008)

Treatment of adults with attention-deficit/hyperactivity disorder
por: Kolar, Dusan, et al.
Publicado: (2008)

Animal models of attention-deficit hyperactivity disorder
por: Russell, Vivienne A, et al.
Publicado: (2005)

Attention Deficit Hyperactivity Disorder in Epileptic Children
por: Kim, Gun-Ha, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hd0u4goort4uvftumldsc65cpg